Aflatoxin B1 induced renal and cardiac damage in rats: Protective effect of lycopene

dc.contributor.authorYilmaz, Seval
dc.contributor.authorKaya, Emre
dc.contributor.authorKaraca, Aysegul
dc.contributor.authorKaratas, Ozhan
dc.date.accessioned2026-08-12T17:33:45Z
dc.date.issued2018
dc.departmentFırat Üniversitesi
dc.description.abstractThis study was conducted to investigate the protective effects of lycopene against the toxic effects of Aflatoxin B-1 (AFB(1)) exposure in kidney and heart of rat by evaluating antioxidant defense systems and lipid peroxidation (LPO). Forty-two healthy three-month-old male Wistar-Albino rats were used in this study. The animals were randomly divided into six experimental groups including 7 rats in each. These groups were arranged as follows: control group, lycopene (5 mg/kg/day, orally for 15 days) group, AFB(1) (0.5 mg/kg/day, orally for 7 days) group, AFB(1) (1.5 mg/kg/day, orally for 3 days) group, AFB(1)(0.5 mg/kg/day, orally for 7 days) + lycopene (5 mg/kg/ day, orally for 15 days) group and AFB(1) (1.5 mg/kg/day, orally for 3 days) + lycopene (5 mg/kg/day, orally for 15 days) group. The animals were sacrificed at the end of applications. In this study, malondialdehyde (MDA) levels significantly increased; while reduced glutathione (GSH), glutathione-S-transferase (GST), catalase (CAT), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and glucose-6-phosphate-dehydrogenase (G6PD) activities decreased in kidney and heart tissues. The significant reduction in the activities of antioxidant enzymes and non-enzymatic antioxidant system in AF treated rats as compared to the control group could be responsible for increased MDA levels observed during AF induced kidney and heart damage. The results showed increased urea, creatinine levels, as well as reduction sodium concentrations in plasma of AFB(1 )treated rats. There was lycopene showed protection against AF induced nephrotoxicity and cardiotoxicity.
dc.identifier.doi10.1016/j.rvsc.2018.07.007
dc.identifier.endpage275
dc.identifier.issn0034-5288
dc.identifier.issn1532-2661
dc.identifier.orcid0000-0002-2040-9247
dc.identifier.orcid0000-0002-7445-3091
dc.identifier.orcid0000-0002-2778-8059
dc.identifier.pmid30059796
dc.identifier.scopus2-s2.0-85050470477
dc.identifier.scopusqualityQ1
dc.identifier.startpage268
dc.identifier.urihttps://doi.org/10.1016/j.rvsc.2018.07.007
dc.identifier.urihttps://hdl.handle.net/11508/57138
dc.identifier.volume119
dc.identifier.wosWOS:000443668400042
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Sci Ltd
dc.relation.ispartofResearch in Veterinary Science
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectAflatoxin
dc.subjectMalondialdehyde
dc.subjectAntioxidant
dc.subjectKidney
dc.subjectHeart
dc.subjectLycopene
dc.titleAflatoxin B1 induced renal and cardiac damage in rats: Protective effect of lycopene
dc.typeArticle

Dosyalar